Immune Gene Expression Analysis of Bladder Carcinoma in-situ and Correlation with CK20 Immunohistochemical Staining and Response to BCG Treatment

被引：0
|
作者：
Lombardo, Kara [1 ]
Amador, Belkiss Murati [2 ]
Parimi , Vamsi [3 ]
McGuire, Bridget [4 ]
Matoso, Andres [1 ]
机构：
[1] Johns Hopkins Med Inst, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[3] Johns Hopkins Univ, Sch Med, Elkridge, MD USA
[4] Johns Hopkins Univ, Sch Med, Greenberg Bladder Canc Inst, Baltimore, MD USA
来源：
LABORATORY INVESTIGATION | 2020年 / 100卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
960
引用
收藏
页码：924 / 925
页数：2
相关论文
共 50 条
  • [1] Immune Gene Expression Analysis of Bladder Carcinoma in-situ and Correlation with CK20 Immunohistochemical Staining and Response to BCG Treatment
    Lombardo, Kara
    Amador, Belkiss Murati
    Parimi , Vamsi
    McGuire, Bridget
    Matoso, Andres
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 924 - 925
  • [2] Urothelial Carcinoma In Situ of the Bladder: Correlation of CK20 Expression With Adaptive Immune Resistance, Response to BCG Therapy, and Clinical Outcome
    Lombardo, Kara A.
    Murati Amador, Belkiss
    Parimi, Vamsi
    Hoffman-Censits, Jean
    Choi, Woonyoung
    Hahn, Noah M.
    Kates, Max
    Bivalacqua, Trinity J.
    McConkey, David
    Hoque, Mohammad O.
    Matoso, Andres
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2021, 29 (02) : 127 - 135
  • [3] Expression of CK7 and CK20 staining in mutinous breast carcinoma
    Greene, LA
    Kida, M
    Beatty, BJ
    Simmons-Arnold, L
    Cooper, K
    MODERN PATHOLOGY, 2003, 16 (01) : 31A - 31A
  • [4] Expression of CK7 and CK20 staining in mucinous breast carcinoma
    Greene, LA
    Kida, M
    Beatty, BJ
    Simmons-Arnold, L
    Cooper, K
    LABORATORY INVESTIGATION, 2003, 83 (01) : 31A - 31A
  • [5] Immunohistochemical expression of GATA3, CK5/6 and CK20 in molecular subtypes of bladder carcinoma: correlation with clinicopathological features
    Noha N. Yassen
    Sonia L. ELsharkawy
    Naglaa F. Abbas
    Marwa E. Shabana
    Bulletin of the National Research Centre, 48 (1)
  • [6] CK20 and p53 Immunohistochemical Staining Patterns in Urinary Bladder Specimens With Equivocal Atypia Correlation With Outcomes
    Arias-Stella, Javier A., III
    Shah, Alpa B.
    Gupta, Nilesh S.
    Williamson, Sean R.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2018, 142 (01) : 64 - 69
  • [7] DIAGNOSTIC AND PROGNOSTIC POTENTIAL OF CK20 GENE EXPRESSION IN PATIENTS WITH TRANSITIONAL-CELL CARCINOMA OF THE URINARY BLADDER
    Singh, P. K.
    Srivastava, A.
    Singh, P.
    Singh, D.
    Dalela, D.
    Goel, M.
    Gupta, S.
    Negi, M. P. S.
    Bhatt, M.
    Rath, S.
    EJC SUPPLEMENTS, 2011, 9 (01): : 14 - 15
  • [8] A systematic review and meta-analysis of CK20, CD44, Ki67 and p53 as immunohistochemical markers in bladder carcinoma in situ
    Straccia, P.
    Fiorentino, V.
    Martini, M.
    Pierconti, F.
    ACTAS UROLOGICAS ESPANOLAS, 2022, 46 (09): : 521 - 530
  • [9] BCG TREATMENT OF EXISTING TA, T1 TUMORS OR CARCINOMA IN-SITU OF THE BLADDER
    AKAZA, H
    EUROPEAN UROLOGY, 1995, 27 : 9 - 12
  • [10] Diagnostic Roles of Immunohistochemical Markers CK20, CD44, AMACR, and p53 in Urothelial Carcinoma In Situ
    Yoo, Daeseon
    Min, Kyueng-Whan
    Pyo, Jung-Soo
    Kim, Nae Yu
    MEDICINA-LITHUANIA, 2023, 59 (09):
12345